Delivery Order SPE2DE24D0021-SPE2D625F2ZR7
- Not listed
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $10,700.70 on June 6, 2025, for the supply of PCR DNA polymerase kit components with single-step substrate script 3 plating capabilities. The contract, which extends through June 30, 2025, supports the Defense Medical Supply Chain and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger procurement vehicle and was awarded through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,230.00 on August 22, 2025, for the procurement of a kit containing real-time polymerase chain reaction (PCR) DNA primer with a single-step protocol and probe for detection purposes. The contract, which is fixed price with economic price adjustment pricing, is classified as a child contract and was issued without a set-aside designation. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion...
- Fisher Scientific Company L.L.C. was awarded a $3,956.00 delivery order contract on June 18, 2025, for kit real-time polymerase chain reaction (RT PCR) RNA with 1 step builtin hot start gel. This fixed-price contract with economic price adjustment has an ultimate completion date of July 1, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was awarded by the Medical Supply Chain, a defense-focused federal agency, with no set-aside designation applied. As a child contract...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,675.00 by the Medical Supply Chain, a defense-focused federal agency, on July 11, 2025. The contract, which carries an economic price adjustment provision, is designated as a child contract under a larger vehicle and requires completion by July 21, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents an open competition award with no set-aside designation, consistent...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $8,256.00 from the Medical Supply Chain, a defense-oriented federal agency, on April 24, 2025. The contract covers the procurement of PCR enclosures and purification filter PCR enclosures with monitoring capabilities, with performance to be completed in Pittsburgh, Pennsylvania by June 6, 2025. This delivery order is structured as a fixed-price contract with economic price adjustment provisions and represents a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,911.80 on September 3, 2025, for the supply of a kit for reverse transcription polymerase chain reaction (RT PCR) 96-well plate region of interest testing. The contract is a fixed price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 15, 2025. The award was made without a set-aside designation through open competition, and performance will take place in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,260.00 on August 15, 2025, for the procurement of kit reverse transcription polymerase chain reaction (RT-PCR) reagents with reduced ribonucleic acid (RNA) activity. This fixed-price delivery order with economic price adjustment falls under the Defense or Civilian agency designation of Medical Supply Chain and is scheduled for completion by August 29, 2025. The contract represents a child award and does not utilize a...
- Fisher Scientific Company L.L.C. has been awarded a fixed-price delivery order valued at $6,420.42 for one kit of real-time polymerase chain reaction (PCR) DNA primer with single-step substrate and caption plates, to be delivered to Pittsburgh, Pennsylvania. The contract was awarded on August 28, 2025, with an ultimate completion date of September 17, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition to support the Medical...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory supplies and scientific equipment, was awarded a delivery order valued at $4,430.32 by the Department of Defense's Medical Supply Chain agency on August 8, 2025. This fixed-price delivery order with economic price adjustment clause is classified as a child contract, indicating it derives from a larger procurement vehicle. The order is scheduled for completion by August 22, 2025, with performance taking place at Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,782.05 for FG TaqMan Fast Universal PCR supplies on July 29, 2025, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment was awarded without a set-aside designation by the Medical Supply Chain division of the Defense Department. The work will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a discrete...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2ZR7Delivery Order
Fisher Scientific Company L.L.C., a major supplier of laboratory and medical equipment to federal agencies, received a $2,140.14 fixed-price delivery order from the Defense Department's Medical Supply Chain division on June 18, 2025. The contract covers procurement of a kit for real-time polymerase chain reaction (PCR) DNA polymerase, single-step substrate, and related 3-plate configuration materials. Performance will take place in Pittsburgh, Pennsylvania, with an ultimate completion date of July 11, 2025. This delivery order was awarded without set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The contract includes economic price adjustment provisions and represents a child contract within a larger procurement vehicle. Fisher Scientific's selection for this procurement reflects its established role as a critical vendor for specialized laboratory supplies and testing solutions across multiple federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and various defense-related organizations. The company's extensive portfolio of contract awards demonstrates consistent capability in delivering advanced scientific instruments and reagents to support federal research, healthcare, and testing initiatives. As a registered SAM.gov vendor since 2001, Fisher Scientific has built substantial relationships with government agencies seeking high-quality molecular biology and diagnostic testing materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/18/25 |